IL118219A0 - Antifungal compositions - Google Patents

Antifungal compositions

Info

Publication number
IL118219A0
IL118219A0 IL11821995A IL11821995A IL118219A0 IL 118219 A0 IL118219 A0 IL 118219A0 IL 11821995 A IL11821995 A IL 11821995A IL 11821995 A IL11821995 A IL 11821995A IL 118219 A0 IL118219 A0 IL 118219A0
Authority
IL
Israel
Prior art keywords
pct
date nov
azole
sec
antifungal compositions
Prior art date
Application number
IL11821995A
Other languages
English (en)
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IL118219A0 publication Critical patent/IL118219A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Materials For Medical Uses (AREA)
IL11821995A 1995-05-12 1996-05-10 Antifungal compositions IL118219A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9509631.9A GB9509631D0 (en) 1995-05-12 1995-05-12 Antifungal combination

Publications (1)

Publication Number Publication Date
IL118219A0 true IL118219A0 (en) 1996-09-12

Family

ID=10774361

Family Applications (2)

Application Number Title Priority Date Filing Date
IL11821996A IL118219A (en) 1995-05-12 1996-05-10 Antifungal compositions comprising terbinafine and an azole, their use in the preparation of a medicament and process for their preparation
IL11821995A IL118219A0 (en) 1995-05-12 1996-05-10 Antifungal compositions

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IL11821996A IL118219A (en) 1995-05-12 1996-05-10 Antifungal compositions comprising terbinafine and an azole, their use in the preparation of a medicament and process for their preparation

Country Status (26)

Country Link
US (1) US5985906A (fr)
EP (1) EP0824350B1 (fr)
JP (1) JPH11504931A (fr)
KR (1) KR100443535B1 (fr)
CN (1) CN1100539C (fr)
AT (1) ATE246504T1 (fr)
AU (1) AU712914B2 (fr)
CA (1) CA2219651C (fr)
CY (1) CY2496B1 (fr)
CZ (1) CZ291144B6 (fr)
DE (1) DE69629367T2 (fr)
DK (1) DK0824350T3 (fr)
ES (1) ES2205042T3 (fr)
FI (1) FI120079B (fr)
GB (1) GB9509631D0 (fr)
HK (1) HK1016064A1 (fr)
HU (1) HU224920B1 (fr)
IL (2) IL118219A (fr)
MX (1) MX9708699A (fr)
NO (1) NO317030B1 (fr)
PL (1) PL322749A1 (fr)
PT (1) PT824350E (fr)
SK (1) SK150797A3 (fr)
TW (1) TW464492B (fr)
WO (1) WO1996035423A1 (fr)
ZA (1) ZA963754B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6187757B1 (en) * 1995-06-07 2001-02-13 Ariad Pharmaceuticals, Inc. Regulation of biological events using novel compounds
DE60010098T2 (de) * 1999-08-24 2005-03-31 Ariad Gene Therapeutics, Inc., Cambridge 28-epirapaloge
US7067526B1 (en) 1999-08-24 2006-06-27 Ariad Gene Therapeutics, Inc. 28-epirapalogs
GB0001315D0 (en) * 2000-01-20 2000-03-08 Novartis Ag Organic compounds
GB0003932D0 (en) * 2000-02-18 2000-04-12 Novartis Ag Pharmaceutical compositions
US6673373B2 (en) 2001-02-01 2004-01-06 Carlsbad Technology Inc. Antifungal formulation and the methods for manufacturing and using the same
US7244703B2 (en) 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
WO2004060346A2 (fr) 2002-12-30 2004-07-22 Angiotech International Ag Liberation de medicaments a partir d'une composition polymere a gelification rapide
KR100978717B1 (ko) 2003-12-08 2010-08-30 씨펙스 파마슈티칼스, 인코포레이티드 인슐린 치료를 위한 약제 조성물 및 방법
US20060078580A1 (en) 2004-10-08 2006-04-13 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US7740875B2 (en) * 2004-10-08 2010-06-22 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
SI1867332T1 (sl) 2005-04-07 2011-11-30 Toyama Chemical Co Ltd Farmacevtska sestava in postopek z rabo v kombinaciji s protiglivičnim sredstvom
JP5132569B2 (ja) * 2006-10-06 2013-01-30 富山化学工業株式会社 フェニルアミジン誘導体を含有する医薬組成物および抗真菌剤を組み合わせて使用する方法
JP2010512343A (ja) * 2006-12-08 2010-04-22 オースペックス・ファーマシューティカルズ・インコーポレイテッド 置換アリルアミン類の調製および実用性
US8921642B2 (en) 2008-01-11 2014-12-30 Massachusetts Eye And Ear Infirmary Conditional-stop dimerizable caspase transgenic animals
CA2905229C (fr) 2013-06-11 2023-10-10 Clontech Laboratories, Inc. Microvesicules enrichies en proteines et leurs procedes de fabrication et d'utilisation

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4144346A (en) * 1977-01-31 1979-03-13 Janssen Pharmaceutica N.V. Novel 1-(1,3-dioxolan-2-ylmethyl)-1H-imidazoles
US4218458A (en) * 1978-06-23 1980-08-19 Janssen Pharmaceutica, N.V. Heterocyclic derivatives of (4-aryloxy-methyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles
GB2099818A (en) * 1981-06-06 1982-12-15 Pfizer Ltd Triazoles
US4782059A (en) * 1986-09-29 1988-11-01 Merck & Co., Inc. Method of controlling mycotic infections and compositions therefor
JP2581707B2 (ja) * 1987-10-02 1997-02-12 科研製薬株式会社 抗真菌剤組成物
CA2016738A1 (fr) * 1989-06-08 1990-12-08 Philippe Guerry Derives d'aminoalkylbenzene substitues
JPH0338522A (ja) * 1989-07-05 1991-02-19 Maruho Kk 抗真菌性組成物
JPH0338521A (ja) * 1989-07-05 1991-02-19 Maruho Kk 抗真菌性組成物
CA2020888A1 (fr) * 1989-07-27 1991-01-28 Philippe Guerry Derives d'aminoalkoxybenzene substitues
US5214046A (en) * 1989-07-27 1993-05-25 Hoffmann-La Roche Inc. Substituted aminoalkoxybenzene anti-fungicidal compositions and use
CA2044533A1 (fr) * 1990-06-29 1991-12-30 Philippe Guerry Derives aminoalkylbiphenyliques substitues
US5696164A (en) * 1994-12-22 1997-12-09 Johnson & Johnson Consumer Products, Inc. Antifungal treatment of nails
JP3038522U (ja) 1996-12-05 1997-06-20 秀俊 筬 カード型紙箱ポプリ
JP3038521U (ja) 1996-12-05 1997-06-20 啓次 小峰 排泄物一時保持具用の水溶繊維製ステック状吸液材

Also Published As

Publication number Publication date
FI120079B (fi) 2009-06-30
DE69629367T2 (de) 2004-06-09
HU224920B1 (en) 2006-04-28
ATE246504T1 (de) 2003-08-15
JPH11504931A (ja) 1999-05-11
ES2205042T3 (es) 2004-05-01
SK150797A3 (en) 1998-05-06
CA2219651A1 (fr) 1996-11-14
CY2496B1 (en) 2005-09-02
KR19990014708A (ko) 1999-02-25
FI973812A (fi) 1997-11-11
EP0824350A1 (fr) 1998-02-25
FI973812A0 (fi) 1997-09-26
CA2219651C (fr) 2007-03-27
MX9708699A (es) 1998-02-28
NO975134L (no) 1997-11-07
NO317030B1 (no) 2004-07-26
PL322749A1 (en) 1998-02-16
HUP9801140A3 (en) 2000-07-28
CN1100539C (zh) 2003-02-05
DE69629367D1 (de) 2003-09-11
AU5818396A (en) 1996-11-29
GB9509631D0 (en) 1995-07-05
EP0824350B1 (fr) 2003-08-06
TW464492B (en) 2001-11-21
AU712914B2 (en) 1999-11-18
HK1016064A1 (en) 1999-10-29
CZ291144B6 (cs) 2002-12-11
KR100443535B1 (ko) 2004-12-17
CZ354797A3 (cs) 1998-02-18
IL118219A (en) 2001-08-26
PT824350E (pt) 2003-12-31
WO1996035423A1 (fr) 1996-11-14
US5985906A (en) 1999-11-16
CN1184427A (zh) 1998-06-10
NO975134D0 (no) 1997-11-07
ZA963754B (en) 1997-11-10
DK0824350T3 (da) 2003-11-03
HUP9801140A2 (hu) 1999-01-28

Similar Documents

Publication Publication Date Title
IL118219A0 (en) Antifungal compositions
LU93229I2 (fr) "pitolisant et ses sels pharmaceutiquement acceptables, tel que chlorhydrate"
AP9701018A0 (en) Squalene synthetase inhibitor compounds.
IL139080A0 (en) Btx inhibitors and methods for their indentification and use
PT1355889E (pt) Derivados diamina triazole substituidos como inibidores de cinase
MXPA03000686A (es) Acoplamiento eficiente de ullmann mediado por ligandos de anilinas y azoles.
DE69431194D1 (de) Amidino-derivate nützlich als no synthase-hemmer
GB9317636D0 (en) Use of dexmedetomidine
NZ300942A (en) 1-aryl-2-acylamino-ethane derivatives as neurokinin 1 antagonists
IL116887A0 (en) Cationic copolymers of vinyl amine and vinyl alcohol for the delivery of oligonucleotides
RS51092B (sr) Escitalopram bromhidrat i postupak za njegovo pripremanje
PT1235579E (pt) Composicoes farmaceuticas contendo trimegestona
NO981019L (no) Deodoriserende preparater inneholdende kationiske biopolymerer, aluminiumklorhydrat og esteraseinhibitorer
IL152908A0 (en) USE OF (+)-a- (2,3-DIMETHOXYPHENYL)-1-[2-(4-FLUOROPHENYL) ETHYL] -4-PIPERIDINEMETHANOL OR ITS PRODRUG IN THE TREATMENT OF SYMPTOMS OF DEMENTIA AND DOPAMINE INDUCED PSYCHOSIS
ATE213782T1 (de) Verfahren zur biotransformation von colchicinoid- verbindungen in die entsprechenden 3- glycosylderivate
WO2001004354A3 (fr) Procedes permettant d'inhiber l'amyotrophie
ES2136615T3 (es) Nuevos inhibidores de glucohidrolasa utiles como agentes antidiabeticos, antiviricos y antimetastasicos.
PL323305A1 (en) Applications of allyl amines
ITGE950050A0 (it) Pressa punzonatrice-roditrice per lamiere metalliche, o simili.
ITMI20000908A0 (it) Metodo e sistema per l'assicurazione di un investimento in titoli azionari e similari.
DE59702821D1 (en) Dimethyl-substituierte cyclohexandienderivate
UA42111C2 (uk) Засіб для прихованого маркування небіологічних об'єктів
GEP20033018B (en) Method for Flexographic Printing
MX9709450A (es) Piridiniminil-1,2-benzoisoxazoles y -benzoisotiazoles como agentes antipsicoticos.